Clinical Trial Update: Cimicoxib for the Treatment of Major Depression (SECIM) [Phase 2]

View source ↗

Summary

Phase 2 trial of Cimicoxib for major depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Cimicoxib

Snippet

Sponsor: Affectis Pharmaceuticals AG | Conditions: Major Depression | Phase 2 | Status: COMPLETED